Testing effectiveness (Phase 2)UnknownNCT03580291What this trial is testingHuman Umbilical Cord Mesenchymal Stem Cells Treatment for Lupus Nephritis (LN)Who this might be right forLupus Nephritis Lingyun Sun 230
Testing effectiveness (Phase 2)Ended earlyNCT04564339What this trial is testingStudy of Ravulizumab in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN)Who this might be right forLupus NephritisImmunoglobulin A Nephropathy Alexion Pharmaceuticals, Inc. 123
Not applicableStudy completedNCT01156428What this trial is testingInflammatory and Immune Profiling of Kidney Tissue Obtained From Patients With Newly Diagnosed Kidney DiseaseWho this might be right forProteinuriaKidney InjuryChronic Kidney Disease The Rogosin Institute 119
Testing effectiveness (Phase 2)UnknownNCT02936375What this trial is testingThe Iguratimod Effect on Lupus Nephritis (IGeLU)Who this might be right forLupus Nephritis RenJi Hospital 120
Testing effectiveness (Phase 2)Study completedNCT02141672What this trial is testingAURA-LV: Aurinia Urinary Protein Reduction Active - Lupus With Voclosporin (AURA-LV)Who this might be right forLupus Nephritis Aurinia Pharmaceuticals Inc. 265
Large-scale testing (Phase 3)Study completedNCT01639339What this trial is testingEfficacy and Safety of Belimumab in Patients With Active Lupus NephritisWho this might be right forLupus Nephritis Human Genome Sciences Inc., a GSK Company 448
Early research (Phase 1)Looking for participantsNCT07491900What this trial is testingHB2198 in Participants With Moderately to Severely Active Systemic Lupus Erythematosus (SLE)Who this might be right forSystemic Lupus Erthematosus (SLE)Lupus Nephritis (LN)Extra-renal Lupus (ERL) Hinge Bio 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT05798117What this trial is testingAn Open-label, Study to Assess Safety, Efficacy and Cellular Kinetics of YTB323 in Severe, Refractory Systemic Lupus ErythematosusWho this might be right forSystemic Lupus ErythematosusLupus Nephritis Novartis Pharmaceuticals 21
Not applicableStudy completedNCT00935389What this trial is testingProspective Study of TW in the Treatment of LN Type V With Gross ProteinuriaWho this might be right forLupus NephritisProteinuriaCTX Nanjing University School of Medicine 44
Not applicableNot Yet RecruitingNCT07505576What this trial is testingAnti-alpha-actinin Antibodies and Lupus Nephritis ActivityWho this might be right forLupus Nephritis Assiut University 96
Testing effectiveness (Phase 2)Looking for participantsNCT05268289What this trial is testingStudy of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- VWho this might be right forLupus Nephritis Novartis Pharmaceuticals 240
Early research (Phase 1)Active Not RecruitingNCT06265220What this trial is testingAB-101 in Combination With B-Cell Depleting mAb in Patients Who Failed Treatment for Class III or IV Lupus Nephritis or Other Forms of Refractory Systemic Lupus ErythematosusWho this might be right forLupus Nephritis - WHO Class IIILupus Nephritis - WHO Class IVRefractory Systemic Lupus Erythematosus+1 more Artiva Biotherapeutics, Inc. 51
Testing effectiveness (Phase 2)Looking for participantsNCT05680480What this trial is testingTelitacicept in Lupus NephritisWho this might be right forLupus Nephritis RemeGen Co., Ltd. 120
Early research (Phase 1)Looking for participantsNCT07236762What this trial is testingAn Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune DiseasesWho this might be right forSystemic Lupus ErythematosusLupus Nephritis (LN)Sjogren's Syndrome+3 more China Immunotech (Beijing) Biotechnology Co., Ltd. 18
Early research (Phase 1)Looking for participantsNCT06285279What this trial is testingThe BCMA/CD19 Dual Targeted CAR-T Cell in Participants With Autoimmune Kidney DiseasesWho this might be right forLupus NephritisANCA-associated VasculitisMembranous Nephropathy - PLA2R Induced+1 more Nanjing University School of Medicine 24
Large-scale testing (Phase 3)UnknownNCT05631717What this trial is testingThe Study of Comparing the Efficacy and Safety of Human Umbilical Cord MSCs and Low-dose IL-2 in the Treatment of LNWho this might be right forSystemic Lupus ErythematosusLupus Nephritis The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 40
Large-scale testing (Phase 3)Study completedNCT02457221What this trial is testingCompare the Efficacy and Safety of Tacrolimus Capsules and Cyclophosphamide Injection in Treatment of Lupus NephritisWho this might be right forLupus Nephritis Astellas Pharma China, Inc. 314
Large-scale testing (Phase 3)Ended earlyNCT02081183What this trial is testingEvaluate Efficacy of CellCept (Mycophenolate Mofetil) in Patients With Lupus NephritisWho this might be right forLupus Nephritis Hoffmann-La Roche 16
Not applicableLooking for participantsNCT06277427What this trial is testingRefractory ANCA Associated Vasculitis and Lupus Nephritis Treated With BCMA-targeting CAR-T CellsWho this might be right forLupus NephritisANCA Associated Vasculitis Lingli Dong 24
Large-scale testing (Phase 3)Ended earlyNCT04181762What this trial is testingStudy of Safety, Efficacy and Tolerability of Secukinumab Versus Placebo, in Combination With SoC Therapy, in Patients With Active Lupus NephritisWho this might be right forLupus Nephritis Novartis Pharmaceuticals 275